Global Skin 3D Bioprinting Market

Global Skin 3D Bioprinting Market Size, Trends & Analysis - Forecasts to 2026 By Component (3D Bioprinters [Microextrusion, Inkjet 3D, Laser-Assisted, Magnetic], Bioinks [Natural, Hybrid, Synthetic]), By Material (Hydrogels, Extracellular Matrices), By End-Use (Research Organizations & Academic Institutes, Hospitals), By Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on November 16 2024 with the latest and most recent market numbers

Skin 3D Bioprinting Market Insights

Increasing 3D imensional technology adoption in biotechnology, cosmetology, and pharmaceutical industries owing to its effective solutions and long-term sustainability will result in high investment in the niche medical sector. The emergence of public and private funding to accelerate the bioprinting research in the healthcare sector will promote the Skin 3D Bioprinting Market growth. Increasing acceptance among surgeons and patients to trust in novel technologies will strengthen the overall investment in these sectors.

In the case of burns accident, the major concern which is always left out is the optimum healing of the burn scar. Previously, the absence of proper treatment or inefficient cell development pertaining to tissue regeneration has resulted in leaving scars on the patient body. Thus, the introduction of these technologies will offer a hundred percent success rate in terms of wound closure and healing.

Change in patient’s psychology due to trauma and scar may result in life long psychological issue. Therefore, the ideal treatment is required to provide a normal functional life to the patient. The Skin 3D Bioprinting is an optimal solution to combat the trauma caused during the incident. The emergence of artificial intelligence and other technological advancements to promote the best treatment and solutions in tissue regeneration will promote industry expansion.

The presence of various components, materials, and production technology makes the industry more result-oriented in nature. Also, investments from government bodies to upgrade the healthcare sector will support industry growth.

global skin 3d bioprinting market

Skin 3D Bioprinting Market: By Component

Based on components, the market is segmented into 3D Bioprinters and Bioinks. The 3D Bioprinters are further sub-segmented into microextrusion, laser-assisted, and magnetic Bioprinters. The magnetic bioprintersare projected to attain maximum share over the forecast period. High suitability in tissue engineering along with compatibility in terms of cell generation will promote growth in this segment.

Laser-assisted components are effective tools to build the tissue in less time. However, the mild chances of problems with sensitive membranesmay impact the overall procedure. Improved recovery, positive physiological impact on the patient, along with effective wound closureare major concerning factors in the industry before choosing the component type.

Skin 3D Bioprinting Market: By Material

Hydrogels and extracellular matrices are key identified materials in the skinbioprintingmarket. Hydrogels led the material segment and are expected to continue their dominance over the forecast period. Advantages pertaining to effective burn repairing and healing owing to its moisture control & water content properties will result in high demand for hydrogel-based components. Efficient cell encapsulation, tissue architecture, and cell construction are among the key success factors to adopt hydrogel as a primary material in the Skin 3D bioprinting process. The extracellular matrices play an important role in maintaining the normal physiologic properties required in the skin. Other advantages such as tensile strength, cell proliferation & migration, and orientation in burn healing will support the material penetration.

Skin 3D Bioprinting Market: By End-Use

Research organizations & academic institutes and hospitals are two major end-users in the Skin 3D Bioprinting market. Hospitals are projected to witness the highest gains over the forecast period. Rapid requirement for skin regeneration treatments to heal the patients fully from burns or accidents will influence fast adoption. The traditional methods are not a hundred percent effective and do not contain all cell types. Thus, the adoption of this novel technology is promising and achievable.

Research organizations & academic institutes accounted for a significant share in the industry. Inclination towards research and development to build a sustainable and transformative technology will result in high spending in this segment. Change in a patient's perspective to go beyond survival and more focus towards improved scar, wound closure, and functionality will influence the growth.

asia pacific skin 3d bioprinting market

Skin 3D Bioprinting Market: By Region

The North America Skin 3D Bioprinting market will hold a significant share during the forecast period. Increasing burn incidents and accidents causing skin damage will instigate skinbioprinting adoption in the region. Rising investment in novel technologies to enhance the healthcare sector will fuel the regional demand.

The Asia Pacific will witness the highest gains in the coming years. Biotechnological advancement and healthcare industry expansion to bring advanced medical solutions into practice will influence the regional industry expansion. Growing foreign medical tourism in China, Singapore, and India due to wide medical facilities will penetrate the market development.

Skin 3D Bioprinting Market Share and Competitor Analysis

The global market players include AlleviInc, Advanced Solutions Life Sciences, Aspect Biosystems Ltd, Cyfuse Biomedical K.K, Cellink, Digilab, Inc, Gesim, Envisiontec, Nano3D Biosciences, Inc., Poietis, Organovo Holdings, Inc, Regenhu, Rokit Healthcare, Regenovo Biotechnology Co., Ltd, and Tevido Biodevices among others.

Please note: This is not an exhaustive list of companies profiled in the report.

The global industry share is nicheand at the development stage in nature owing to the innovative technology introduction and various technologies are at the development stage and in the pipeline. Application development and patentswill be the major strategies in the coming years. Mergers and partnerships between government and research institutes for funding can be witnessed.

Chapter 1 Methodology

1.1 Market scope & definitions

1.2 Estimates & forecast calculation

1.3 Historical data overview and validation

1.4 Data sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Skin 3D Bioprinting industry overview, 2016-2026

2.1.1 Industry overview

2.1.2 Component overview

2.1.3 Material overview

2.1.4 End-Use overview

2.1.5 Regional overview

Chapter 3 Skin 3D Bioprinting Market Trends

3.1 Market segmentation

3.2 Industry background, 2016-2026

3.3 Market key trends

3.3.1 Positive trends

3.3.2 Industry challenges

3.4 Prospective growth scenario

3.4.1 Application growth scenario

3.4.2 End-Use growth scenario

3.5 COVID-19 influence over industry growth

3.6 Porter’s analysis

3.7 PESTEL analysis

3.8 Value chain & supply chain analysis

3.9 Regulatory framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 Technology overview

3.11 Market share analysis, 2020

3.11.1 Company positioning overview, 2020

Chapter 4 Skin 3D Bioprinting Market, By Component

4.1 Component Outlook

4.2 3D Bioprinters

4.2.1 Market size, by region, 2016-2026 (USD Million)

4.2.2 Microextrusion

4.2.2.1 Market size, by region, 2016-2026 (USD Million)

4.2.3 Inkjet 3D

4.2.3.1 Market size, by region, 2016-2026 (USD Million)

4.2.4 Laser-Assisted

4.2.4.1 Market size, by region, 2016-2026 (USD Million)

4.2.5 Magnetic

4.2.5.1 Market size, by region, 2016-2026 (USD Million)

4.2.6 Others

4.2.6.1 Market size, by region, 2016-2026 (USD Million)

4.3 Bioinks

4.3.1 Market size, by region, 2016-2026 (USD Million)

4.3.2 Natural

4.2.2.1 Market size, by region, 2016-2026 (USD Million)

4.3.3 Hybrid

4.3.3.1 Market size, by region, 2016-2026 (USD Million)

4.3.4 Synthetic

4.3.4.1 Market size, by region, 2016-2026 (USD Million)

Chapter 5 Skin 3D Bioprinting Market, By Material

5.1 Material Outlook

5.2 Hydrogels

5.2.1 Market size, by region, 2016-2026 (USD Million)

5.3 Extracellular Matrices

5.3.1 Market size, by region, 2016-2026 (USD Million)

5.4 Others

5.4.1 Market size, by region, 2016-2026 (USD Million)

Chapter 6 Skin 3D Bioprinting Market, By End-Use

6.1 End-Use Outlook

6.2 Research Organizations & Academic Institutes

6.2.1 Market size, by region, 2016-2026 (USD Million)

6.3 Hospitals

6.3.1 Market size, by region, 2016-2026 (USD Million)

6.4 Others

6.4.1 Market size, by region, 2016-2026 (USD Million)

Chapter 7 Skin 3D Bioprinting Market, By Region

7.1 Regional outlook

7.2 North America

7.2.1 Market size, by country 2016-2026 (USD Million)

7.2.2 Market size, by component, 2016-2026 (USD Million)

7.2.3 Market size, by material, 2016-2026 (USD Million)

7.2.4 Market size, by end-use, 2016-2026 (USD Million)

7.2.5 U.S.

7.2.5.1 Market size, by component, 2016-2026 (USD Million)

7.2.5.2 Market size, by material, 2016-2026 (USD Million)

7.2.5.3 Market size, by end-use, 2016-2026 (USD Million)

7.2.6 Canada

7.2.6.1 Market size, by component, 2016-2026 (USD Million)

7.2.6.2 Market size, by material, 2016-2026 (USD Million)

7.2.6.3 Market size, by end-use, 2016-2026 (USD Million)

7.3 Europe

7.3.1 Market size, by country 2016-2026 (USD Million)

7.3.2 Market size, by component, 2016-2026 (USD Million)

7.3.3 Market size, by material, 2016-2026 (USD Million)

7.3.4 Market size, by end-use, 2016-2026 (USD Million)

7.3.5 Germany

7.2.5.1 Market size, by component, 2016-2026 (USD Million)

7.2.5.2 Market size, by material, 2016-2026 (USD Million)

7.2.5.3 Market size, by end-use, 2016-2026 (USD Million)

7.3.6 UK

7.3.6.1 Market size, by component, 2016-2026 (USD Million)

7.3.6.2 Market size, by material, 2016-2026 (USD Million)

7.3.6.3 Market size, by end-use, 2016-2026 (USD Million)

7.3.7 France

7.3.7.1 Market size, by component, 2016-2026 (USD Million)

7.3.7.2 Market size, by material, 2016-2026 (USD Million)

7.3.7.3 Market size, by end-use, 2016-2026 (USD Million)

7.3.8 Italy

7.3.8.1 Market size, by component, 2016-2026 (USD Million)

7.3.8.2 Market size, by material, 2016-2026 (USD Million)

7.3.8.3 Market size, by end-use, 2016-2026 (USD Million)

7.3.9 Spain

7.3.9.1 Market size, by component, 2016-2026 (USD Million)

7.3.9.2 Market size, by material, 2016-2026 (USD Million)

7.3.9.3 Market size, by end-use, 2016-2026 (USD Million)

7.3.10 Russia

7.3.10.1 Market size, by component, 2016-2026 (USD Million)

7.3.10.2 Market size, by material, 2016-2026 (USD Million)

7.3.10.3 Market size, by end-use, 2016-2026 (USD Million)

7.4 Asia Pacific

7.4.1 Market size, by country 2016-2026 (USD Million)

7.4.2 Market size, by component, 2016-2026 (USD Million)

7.4.3 Market size, by material, 2016-2026 (USD Million)

7.4.4 Market size, by end-use, 2016-2026 (USD Million)

7.4.5 China

7.4.5.1 Market size, by component, 2016-2026 (USD Million)

7.4.5.2 Market size, by material, 2016-2026 (USD Million)

7.4.5.3 Market size, by end-use, 2016-2026 (USD Million)

7.4.6 India

7.4.6.1 Market size, by component, 2016-2026 (USD Million)

7.4.6.2 Market size, by material, 2016-2026 (USD Million)

7.4.6.3 Market size, by end-use, 2016-2026 (USD Million)

7.4.7 Japan

7.4.7.1 Market size, by component, 2016-2026 (USD Million)

7.4.7.2 Market size, by material, 2016-2026 (USD Million)

7.4.7.3 Market size, by end-use, 2016-2026 (USD Million)

7.4.8 Australia

7.4.8.1 Market size, by component, 2016-2026 (USD Million)

7.4.8.2 Market size, by material, 2016-2026 (USD Million)

7.4.8.3 Market size, by end-use, 2016-2026 (USD Million)

7.4.9 South Korea

7.4.9.1 Market size, by component, 2016-2026 (USD Million)

7.4.9.2 Market size, by material, 2016-2026 (USD Million)

7.4.9.3 Market size, by end-use, 2016-2026 (USD Million)

7.5 Latin America

7.5.1 Market size, by country 2016-2026 (USD Million)

7.5.2 Market size, by component, 2016-2026 (USD Million)

7.5.3 Market size, by material, 2016-2026 (USD Million)

7.5.4 Market size, by end-use, 2016-2026 (USD Million)

7.5.5 Brazil

7.5.5.1 Market size, by component, 2016-2026 (USD Million)

7.5.5.2 Market size, by material, 2016-2026 (USD Million)

7.5.5.3 Market size, by end-use, 2016-2026 (USD Million)

7.5.6 Mexico

7.5.6.1 Market size, by component, 2016-2026 (USD Million)

7.5.6.2 Market size, by material, 2016-2026 (USD Million)

7.5.6.3 Market size, by end-use, 2016-2026 (USD Million)

7.5.7 Argentina

7.5.7.1 Market size, by component, 2016-2026 (USD Million)

7.5.7.2 Market size, by material, 2016-2026 (USD Million)

7.5.7.3 Market size, by end-use, 2016-2026 (USD Million)

7.6 MEA

7.6.1 Market size, by country 2016-2026 (USD Million)

7.6.2 Market size, by component, 2016-2026 (USD Million)

7.6.3 Market size, by material, 2016-2026 (USD Million)

7.6.4 Market size, by end-use, 2016-2026 (USD Million)

7.6.5 Saudi Arabia

7.6.5.1 Market size, by component, 2016-2026 (USD Million)

7.6.5.2 Market size, by material, 2016-2026 (USD Million)

7.6.5.3 Market size, by end-use, 2016-2026 (USD Million)

7.6.6 UAE

7.6.6.1 Market size, by component, 2016-2026 (USD Million)

7.6.6.2 Market size, by material, 2016-2026 (USD Million)

7.6.6.3 Market size, by end-use, 2016-2026 (USD Million)

7.6.7 South Africa

7.6.7.1 Market size, by component, 2016-2026 (USD Million)

7.6.7.2 Market size, by material, 2016-2026 (USD Million)

7.6.7.3 Market size, by end-use, 2016-2026 (USD Million)

Chapter 8 Company Landscape

8.1 Competitive analysis, 2020

8.2 Allevi Inc.

8.2.1 Company overview

8.2.2 Financial analysis

8.2.3 Strategic positioning

8.2.4 Info graphic analysis

8.3 Advanced Solutions Life Sciences

8.3.1 Company overview

8.3.2 Financial analysis

8.3.3 Strategic positioning

8.3.4 Info graphic analysis

8.4 Aspect Biosystems Ltd.

8.4.1 Company overview

8.4.2 Financial analysis

8.4.3 Strategic positioning

8.4.4 Info graphic analysis

8.5 Cyfuse Biomedical K.K.

8.5.1 Company overview

8.5.2 Financial analysis

8.5.3 Strategic positioning

8.5.4 Info graphic analysis

8.6 Cellink

8.6.1 Company overview

8.6.2 Financial analysis

8.6.3 Strategic positioning

8.6.4 Info graphic analysis

8.7 Digilab, Inc.

8.7.1 Company overview

8.7.2 Financial analysis

8.7.3 Strategic positioning

8.7.4 Info graphic analysis

8.8 Gesim

8.8.1 Company overview

8.8.2 Financial analysis

8.8.3 Strategic positioning

8.8.4 Info graphic analysis

8.9 Envisiontec

8.9.1 Company overview

8.9.2 Financial analysis

8.9.3 Strategic positioning

8.9.4 Info graphic analysis

8.10 Nano3D Biosciences, Inc.

8.10.1 Company overview

8.10.2 Financial analysis

8.10.3 Strategic positioning

8.10.4 Info graphic analysis

8.11 Poietis

8.11.1 Company overview

8.11.2 Financial analysis

8.11.3 Strategic positioning

8.11.4 Info graphic analysis

8.12 Organovo Holdings, Inc.

8.12.1 Company overview

8.12.2 Financial analysis

8.12.3 Strategic positioning

8.12.4 Info graphic analysis

8.13 Regenhu

8.13.1 Company overview

8.13.2 Financial analysis

8.13.3 Strategic positioning

8.13.4 Info graphic analysis

8.14 Rokit Healthcare

8.14.1 Company overview

8.14.2 Financial analysis

8.14.3 Strategic positioning

8.14.4 Info graphic analysis

8.15 Regenovo Biotechnology Co., Ltd.

8.15.1 Company overview

8.15.2 Financial analysis

8.15.3 Strategic positioning

8.15.4 Info graphic analysis

8.16 Tevido Biodevices

8.16.1 Company overview

8.16.2 Financial analysis

8.16.3 Strategic positioning

8.16.4 Info graphic analysis

The Global Skin 3D Bioprinting Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Skin 3D Bioprinting Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.